Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  11:36 2022-11-29 am EST
14.08 EUR   +0.67%
11/28Philips debuts new AI-enhanced informatics solutions to increase diagnostic confidence with intelligence at every step of the radiology workflow at RSNA
GL
11/28Philips debuts new AI-enhanced informatics solutions to increase diagnostic confidence with intelligence at every step of the radiology workflow at RSNA
GL
11/28Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right diagnosis for more patients
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

Philips : Voting results and resolution EGM 2022

09/30/2022 | 11:44am EST

Voting results and resolution 2022 EGM Royal Philips

Voting results and summary of the resolution taken at the Extraordinary General Meeting of Shareholders of Koninklijke Philips N.V. held on September 30, 2022.

On the record date for the 2022 EGM (September 2, 2022) the total number of issued shares in Koninklijke Philips N.V. was 889,315,082 ordinary shares. Considering the number of shares held in treasury, which amounted to 3,988,684 on such record date, the number of voting rights amounted to 885,326,398.

Percentages have been rounded.

Agenda item

The General Meeting of Shareholders appointed Mr R.W.O. Jakobs as President/Chief Executive Officer and member of the Board of Management with effect from October 15, 2022.

Overview votes

For

648,349,232

99.77%

Against

1,464,703

0.23%

Abstain

2,631,010

Total shares voted / votes cast

649,813,935

(i.e. excluding abstentions)

73.70% of the issued and outstanding share capital

page 1 of 1 | Voting results and resolution 2022 Extraordinary General Meeting of Shareholders

Disclaimer

Royal Philips NV published this content on 30 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 September 2022 15:43:07 UTC.


ę Publicnow 2022
All news about PHILIPS NV
11/28Philips debuts new AI-enhanced informatics solutions to increase diagnostic confidence ..
GL
11/28Philips debuts new AI-enhanced informatics solutions to increase diagnostic confidence ..
GL
11/28Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right ..
GL
11/28Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right ..
AQ
11/28PHILIPS NV : UBS reiterates its Neutral rating
MD
11/27Philips advances AI-powered diagnostic systems and transformative workflow solutions at..
AQ
11/27Royal Philips Announces Its Portfolio of Smart Diagnostic Systems and Transformative Wo..
CI
11/27Philips advances AI-powered diagnostic systems and transformative workflow solutions at..
GL
11/23Philips Respironics provides update on filed MDRs in connection with the voluntary reca..
AQ
11/23Philips Submitted 21,000 Faulty Foam-Related Medical Device Reports in Three Months to ..
MT
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2022 17 374 M 18 042 M 18 042 M
Net income 2022 -1 445 M -1 501 M -1 501 M
Net Debt 2022 5 815 M 6 039 M 6 039 M
P/E ratio 2022 -10,5x
Yield 2022 5,72%
Capitalization 12 382 M 12 858 M 12 858 M
EV / Sales 2022 1,05x
EV / Sales 2023 1,00x
Nbr of Employees 78 831
Free-Float 99,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 13,99 €
Average target price 15,91 €
Spread / Average Target 13,7%
EPS Revisions
Managers and Directors
Roy Jakobs President & Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Shez Partovi Chief Medical, Innovation & Strategy Officer
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-57.31%12 858
THERMO FISHER SCIENTIFIC-19.07%212 798
DANAHER CORPORATION-20.62%190 115
INTUITIVE SURGICAL, INC.-26.21%92 813
BOSTON SCIENTIFIC CORPORATION3.93%62 721
SIEMENS HEALTHINEERS AG-22.64%59 129